1 year return (CAGR)
-38.11%
Loncar Cancer Immunotherapy ETF Exchange (NASDAQ, USD)
CNCR
-
0.00 (0.00%)
NASDAQ
Loading...
3 year return (CAGR)
-13.81%
5 year return (CAGR)
-19.18%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
-
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
20.55%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 9.02 |
| Daily high | 9.02 |
| Daily low | 9.02 |
| Daily Volume | 0K |
| 1y analyst estimate | - |
| Beta | 0.96 |
| EPS (TTM) | - |
| Dividend per share | 1.85 |
| Ex-div date | 29 Dec 2021 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CNCR | S&P500 | |
| Current price drop from All-time high | -74.73% | -2.75% |
| Highest price drop | -77.56% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -36.25% | -10.68% |
| Avg time to new high | 127 days | 12 days |
| Max time to new high | 1084 days | 1805 days |
News
No items found